Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes
    • eBooks

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Pathology Captures
Subscribe
Subscribe

False

The Pathologist / Issues / 2026 / February / Why Does Ovarian Cancer Spread So Fast
Oncology Biochemistry and molecular biology Clinical care Molecular Pathology Research and Innovations

Why Does Ovarian Cancer Spread So Fast?

New research finds that cancer cells partner the body's own protective cells to drive rapid metastasis

02/23/2026 News 1 min read
  • Full Article
  • Summary
  • Takeaways
  • Listen
  • Report
  • Scorecard
  • Quiz
  • Poll
  • Top Institutions

Share

Top Institutions in Gynecologic Oncology

Leading institutions in gynecologic oncology and cancer biology employ advanced molecular biology, tumor microenvironment analysis, and translational research methodologies to elucidate mechanisms of ovarian cancer metastasis and develop targeted therapies.

  • #1

    Memorial Sloan Kettering Cancer Center

    New York, NY

    MSKCC is a world leader in ovarian cancer research, with extensive programs focused on tumor microenvironment, ascites biology, and novel therapeutic development. Their integrated clinical and laboratory research enables rapid translation of discoveries into clinical trials.

    Key Differentiators

    • Gynecologic Oncology
    • Cancer Biology
    • Translational Research
  • #2

    Dana-Farber Cancer Institute

    Boston, MA

    Dana-Farber has a strong focus on ovarian cancer biology and the tumor microenvironment, with leading research in cancer cell interactions and metastasis mechanisms, supported by collaborations with Harvard Medical School.

    Key Differentiators

    • Gynecologic Oncology
    • Cancer Biology
    • Immunotherapy
  • #3

    MD Anderson Cancer Center

    Houston, TX

    MD Anderson is renowned for its comprehensive ovarian cancer research, including studies on ascites fluid biology and metastatic mechanisms, integrating molecular insights with clinical management strategies.

    Key Differentiators

    • Gynecologic Oncology
    • Cancer Research
    • Molecular Oncology
  • #4

    Johns Hopkins University

    Baltimore, MD

    Johns Hopkins has made significant contributions to understanding ovarian cancer metastasis and the role of the tumor microenvironment, with a focus on cellular interactions in ascites and therapeutic targeting.

    Key Differentiators

    • Gynecologic Oncology
    • Cancer Biology
    • Cellular Microenvironment

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.

Newsletters

Receive the latest pathologist news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Related Content

Turning Tides
Biochemistry and molecular biology
Turning Tides

January 9, 2024

3 min read

A new study shows evidence for sustained human-to-human transmission of mpox since 2016

Molecular Spectacular
Biochemistry and molecular biology
Molecular Spectacular

January 8, 2024

1 min read

A look at last year’s most interesting molecular pathology stories

qPCR Infectious Disease Detective
Biochemistry and molecular biology
qPCR: Infectious Disease Detective

January 4, 2024

3 min read

How quantitative polymerase chain reaction really hits the mark in epidemic control and ID detection

Case of the Month
Biochemistry and molecular biology
Case of the Month

January 11, 2022

1 min read

Affiliations:

Specialties:

Areas of Expertise:

Contributions:

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2026 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.